Press release
Nanoparticle Contract Manufacturing Market Gains Momentum as Pharma Industry Embraces Lipid Nanoparticles for RNA and Gene Therapy
Nanoparticle Contract Manufacturing Market
According to the latest research by InsightAce Analytic, the Global Nanoparticle Contract Manufacturing Market is valued at US$ 2.4 Bn in 2023, and it is expected to reach US$ 4.3 Bn by 2031, with a CAGR of 7.8% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2410
Nanoparticle contract manufacturing is emerging as a sophisticated method for gene delivery within clinical settings. Lipid nanoparticles (LNPs), in particular, play a critical role in the transport of nucleic acids, positioning them as highly effective therapeutic carriers across a variety of treatment modalities. A growing number of pharmaceutical and biotechnology firms are investing in the development of LNP-based therapeutics due to their ability to deliver a wide range of biologically active agents. Nanoparticles are increasingly utilized in the treatment of complex diseases, including cancer, owing to their enhanced permeability and retention characteristics, as well as extended circulation time. These attributes make them especially suited for addressing chronic and hard-to-treat conditions. Moreover, the increasing focus on personalized medicine is anticipated to further accelerate market growth. However, despite the strong potential of this technology, the industry faces significant challenges, notably high production costs and the intricate nature of nanoparticle manufacturing processes, which may hinder broader adoption.
List of Prominent Players in the Nanoparticle Contract Manufacturing Market:
• AstraZeneca
• Evonik Industries AG
• Ascendia Pharmaceuticals
• Axolabs (LGC Limited)
• AVANSA Technology & Services
• Ardena Holding NV.
• Cytodiagnostics, Inc.
• American Elements
• Encapsula NanoSciences LLC
• Fortis Life Sciences
• Hongwu International Group Ltd.
• MyBiotech
• Nanochemazone
• CordenPharma
• LSNE Contract Manufacturing
• Polymun
• TeachNanoIndia
• BIOVECTRA
• Precision NanoSystems
• Emergent BioSolutions
Market Dynamics:
Drivers-
The increasing demand for the nanoparticle contract manufacturing market is driven by the rising prevalence of chronic diseases and an aging population. Nanoparticles possess distinct characteristics, such as enhanced permeability and prolonged circulation, making them particularly effective in treating complex chronic conditions. Additionally, the versatility of nanocarriers enables the delivery of a broad spectrum of therapeutic agents, thereby broadening the potential applications of nanomedicine, particularly in fields such as neurology and oncology.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02
Challenges:
The nanoparticle contract manufacturing market faces several significant obstacles that may hinder its growth trajectory. Key among these are limited technological expertise, a shortage of highly skilled professionals, and the absence of standardized operational protocols, particularly in developing regions. These issues pose operational and quality assurance challenges, slowing the adoption of advanced manufacturing practices. Furthermore, concerns surrounding intellectual property rights and a rising trend of pharmaceutical companies internalizing their manufacturing operations present additional threats to contract manufacturers. As more pharmaceutical firms invest in in-house nanoparticle production capabilities, the reliance on third-party manufacturing partners may decrease, thereby constraining market expansion.
Regional Trends:
North America is expected to command a leading share of the global nanoparticle contract manufacturing market. This dominance is supported by the region's advanced healthcare infrastructure, the strong presence of key pharmaceutical and biotechnology firms, and sustained investment in research and development initiatives. The region's role as a global economic leader further reinforces its market position. Meanwhile, Europe is also experiencing notable growth in this sector, underpinned by a growing commitment to environmentally sustainable manufacturing practices and the increasing utilization of nanoparticles across a range of industrial applications.
Recent Developments:
• In Feb 2024, CordenPharma International has introduced new Lipid NanoParticle (LNP) Starter Kits to enhance the formulation of mRNA in the development of mRNA-based treatments, including mRNA vaccines and gene therapies. The given starter kits equip researchers and developers with the necessary components to establish and enhance their own lipid nanoparticle (LNP) systems for delivering mRNA.
• In July 2023, Ardena, a prominent contract development producer of nanomedicines, has formed a strategic commercial relationship with RiboPro, experts in mRNA and LNP technology. The objective of this collaboration is to improve the worldwide availability of RNA-based healthcare therapies and address a substantial deficiency of skilled personnel within the industry.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2410
Segmentation of Nanoparticle Contract Manufacturing Market-
By Type of Nanoparticles-
• Metal Nanoparticles
• Lipid Nanoparticles
• Others
By Manufacturing Scale-
• Commercial
• Clinical
• Pre-clinical
By Application-
• Therapeutics
• Diagnostics
• Vaccines
By End-user-
• Pharmaceutical Companies
• Biotechnology Companies
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Read Overview Report- https://www.insightaceanalytic.com/report/nanoparticle-contract-manufacturing-market/2410
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nanoparticle Contract Manufacturing Market Gains Momentum as Pharma Industry Embraces Lipid Nanoparticles for RNA and Gene Therapy here
News-ID: 4077569 • Views: …
More Releases from InsightAce Analytic Biosimilar Consulting
Infliximab Biosimilar Market Future Trends and Scope Analysis Report
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Infliximab Biosimilar Market- by Application (Crohn's Disease, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative Colitis, Ankylosing Spondylitis, Plaque Psoriasis and Others), End User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Direct Distribution Channels), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
According to the latest research by InsightAce Analytic, the global Infliximab Biosimilar market is valued…
Testing, Inspection, and Certification Market Deep Research Report with Forecast …
"Global Testing, Inspection, and Certification Market Size, Share & Trends Analysis Report By Service Type (Testing, Inspection, And Certification Services), Sourcing Type (In-House Sourcing And Outsourcing), And Application (Medical & Life Sciences, Consumer Goods & Retail, Agriculture, Chemical, Construction & Infrastructure, Energy & Power, Mining, Oil & Gas, Public Sector, Automotive, Aerospace)- Market Outlook And Industry Analysis 2031"
The global Testing, Inspection, and Certification market is estimated to reach over USD…
Global infliximab biosimilar market is expected to grow at rapid pace with stron …
InsightAce Analytic Pvt. Ltd. announces the release of market assessment report on ' Global Infliximab Biosimilar Market Assessment – Revenue Forecast, Clinical Trial/Pipeline Analysis, Brand/Originator Drug Historic Revenue and Forecast Till 2026'
Infliximab is marketed under the trade/brand name of Remicade. It is developed by Jansen Biotech (Johnson & Johnson) operated as Centocor and was approved by U.S Food Drug Administration (FDA) in 1998 and by European Medicines Agency in 1999.…
More Releases for Nanoparticle
The Role Of Nanoparticle Analysis In Addressing The Rising Prevalence Of Cancer: …
The Nanoparticle Analysis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Nanoparticle Analysis Market?
The expansion of the nanoparticle analysis market has been swift in the previous years. Projections indicate that it will rise from $5.25 billion in 2024…
Lipid-Nanoparticle Based Genomic Medicines Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Lipid-Nanoparticle Based Genomic Medicines Market - (By Type (Liposome-based Nanoparticles, Micelle-based Nanoparticles, Lipid-Coated Nanoparticles), By Application (Cancer Treatment, Infectious Diseases, Genetic Disorders, Cardiovascular Diseases, Others), By Therapeutic Payload (mRNA-based Therapeutics, siRNA-based Therapeutics, miRNA-based Therapeutics, Other Genomic Medicines), By End-User (Hospitals, Biopharmaceutical Companies, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the…
Nanoparticle Analysis Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Nanoparticle Analysis Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The nanoparticle analysis market encompasses a range of technologies and instruments used for the characterization and study of nanoparticles. With the increasing applications of nanoparticles…
Latest Trends In Global Nanoparticle Analyzer Market
A technique for observing and examining particles in liquids is called nanoparticle tracking analysis (NTA). Little particles (between 10 and 1000 nm) are suspended in a liquid using NTA, enabling the creation of a size distribution profile.
Nanotechnology is a vast area of study that focuses on materials and uses that take place at extremely small scales.To determine the size of individual particles and the size distribution range for a…
Cerium Oxide Nanoparticle Market 2022 | Detailed Report
This report provides an informative view about the competitive aspect of the global market. It includes detailed picture of the exhibition of a portion of the essential global players working in the Cerium Oxide Nanoparticle market. The research study also provides historical record with profits predictions and forecasts from 2022 to 2028. Also, the business manufacturing of the notable manufacturers is also emphasized with technical data in the report.
This report…
ORU Scientist Helps Develop Novel Nanoparticle Technology
Tulsa, OK – Oral Roberts University Scientist, Dr. Enrique Valderrama-Araya, who in collaboration with material scientists from Brazil, China, the UK, and the USA, has developed a novel hydrogen evolution reaction for exploring the extent of platinum nanoparticles dissolution upon the surface of carbon nanostructured electrodes.
The team’s research, recently published in Nanoscale, a high impact international journal, demonstrated how platinum nanoparticles can potentially be used to cheaply mass manufacture catalyst…
